Fructooligosaccharides and galactooligosaccharides improve hepatic steatosis via gut microbiota-brain axis modulation

Fructooligosaccharides attenuate non-alcoholic fatty liver disease by remodeling gut microbiota and association with lipid metabolism

(2023) Xiaoqing Huang et al.   BIOMEDICINE & PHARMACOTHERAPY

A multi-society Delphi consensus statement on new fatty liver disease nomenclature

(2023) Mary E. Rinella et al.   JOURNAL OF HEPATOLOGY

Bacteroides acidifaciens in the gut plays a protective role against CD95-mediated liver injury

(2022) Hesuiyuan Wang et al.   Gut Microbes

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC

(2022) Qian Song et al.   Biomedicines

Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases

(2022) Carmine Stolfi et al.   Biomedicines

Obesity I: Overview and molecular and biochemical mechanisms

(2022) Robert H. Lustig et al.   BIOCHEMICAL PHARMACOLOGY

TLR4 mutation protects neurovascular function and cognitive decline in high-fat diet-fed mice

(2022) Nathalie Obadia et al.   Journal of Neuroinflammation

Periodontitis, chronic liver diseases, and the emerging oral‐gut‐liver axis

(2022) Emmanuel Albuquerque‐Souza et al.   PERIODONTOLOGY 2000

Impact of Food-Based Weight Loss Interventions on Gut Microbiome in Individuals with Obesity: A Systematic Review

(2022) Aleisha Bliesner et al.   Nutrients

Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role

(2022) Haripriya Gupta et al.   Biomedicines

GOS Ameliorates Nonalcoholic Fatty Liver Disease Induced by High Fat and High Sugar Diet through Lipid Metabolism and Intestinal Microbes

(2022) Shuting Qiu et al.   Nutrients

Comparative analysis of preventive role of different probiotics and prebiotics against the markers of liver damage, oxidative stress markers and inflammatory markers in the non-alcoholic fatty liver disease induced rats

(2022) Tayyab Shahzad et al.   INTERNATIONAL JOURNAL OF FOOD PROPERTIES

Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion

(2022) Paola Paone et al.   Gut Microbes

Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults

(2021) Jiaye Liu et al.   Clinical Gastroenterology and Hepatology

Inflammation and Atherosclerosis

(2021) Klaus Ley   Cells

Prebiotic Inulin and Sodium Butyrate Attenuate Obesity-Induced Intestinal Barrier Dysfunction by Induction of Antimicrobial Peptides

(2021) Julia Beisner et al.   Frontiers in Immunology

Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis

(2020) Atsuko Takai et al.   BMC GASTROENTEROLOGY

Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: A randomized clinical trial

(2020) Vahideh Behrouz et al.   JOURNAL OF FOOD SCIENCE

Gut microbiota in human metabolic health and disease

(2020) Yong Fan et al.   NATURE REVIEWS MICROBIOLOGY

Prebiotics Supplementation Ameliorates High Fat High Sugar Diet-Associated Oxidative Stress

(2020) Haroon Rashid   PAKISTAN VETERINARY JOURNAL

Leaky gut: mechanisms, measurement and clinical implications in humans

(2019) Michael Camilleri   GUT

Prebiotics from acorn and sago prevent high-fat-diet-induced insulin resistance via microbiome–gut–brain axis modulation

(2019) Shokouh Ahmadi et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

The role of short-chain fatty acids in microbiota–gut–brain communication

(2019) Boushra Dalile et al.   Nature Reviews Gastroenterology & Hepatology

Role of Gut Microbiota in Hepatocarcinogenesis

(2019) Haripriya Gupta et al.   Microorganisms

Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?

(2019) Chencheng Xie et al.   Nutrients

Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial

(2018) Marc R. Bomhof et al.   EUROPEAN JOURNAL OF NUTRITION

Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats

(2018) Titikorn Chunchai et al.   Journal of Neuroinflammation

The role of the gut microbiota in the pathology and prevention of liver disease

(2018) Alejandra Altamirano-Barrera et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

OUP accepted manuscript

(2018)   NUTRITION REVIEWS

Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes

(2018) Liping Zhao et al.   SCIENCE

Inflammatory Links Between High Fat Diets and Diseases

(2018) Yehui Duan et al.   Frontiers in Immunology

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Alpha-Galacto-Oligosaccharides at Low Dose Improve Liver Steatosis in a High-Fat Diet Mouse Model

(2017) Eric Chappuis et al.   MOLECULES

Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice

(2016) J-Y Yang et al.   Mucosal Immunology

Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance

(2016) Luca A Lotta et al.   NATURE GENETICS

The role of the gut microbiota in NAFLD

(2016) Christopher Leung et al.   Nature Reviews Gastroenterology & Hepatology

Changes in Gut Microbiota in Rats Fed a High Fat Diet Correlate with Obesity-Associated Metabolic Parameters

(2015) Virginie Lecomte et al.   PLoS One

The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism

(2014) Gary Frost et al.   Nature Communications

Intestinal microbiota in patients with nonalcoholic fatty liver disease

(2013) Marialena Mouzaki et al.   HEPATOLOGY

GPR43/FFA2: physiopathological relevance and therapeutic prospects

(2013) Laure B. Bindels et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms

(2012) J Gregory Caporaso et al.   ISME Journal

High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway

(2012) Kyung-Ah Kim et al.   PLoS One

Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice

(2011) Amandine Everard et al.   DIABETES

Regulation of Tight Junction Permeability by Intestinal Bacteria and Dietary Components

(2011) Dulantha Ulluwishewa et al.   JOURNAL OF NUTRITION

Prebiotics Improve Intestinal Immunity and Attenuate Oxidative Stress of Constipated Rats

(2011) Yanning Li et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Effects of high-fat diet on plasma lipids, adiposity, and inflammatory markers in ovariectomized C57BL/6 mice

(2011) Antonio Ludgero-Correia et al.   NUTRITION

Obesity, insulin resistance and free fatty acids

(2011) Guenther Boden   Current Opinion in Endocrinology Diabetes and Obesity

Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation

(2010) Claire Barbier de La Serre et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Effects of Probiotics, Prebiotics, and Synbiotics on Messenger RNA Expression of Caveolin-1, NOS, and Genes Regulating Oxidative Stress in the Terminal Ileum of Formula-Fed Neonatal Rats

(2010) Antoni D'Souza et al.   PEDIATRIC RESEARCH

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Conservative Fragments in Bacterial 16S rRNA Genes and Primer Design for 16S Ribosomal DNA Amplicons in Metagenomic Studies

(2009) Yong Wang et al.   PLoS One

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease

(2008) W. Ray Kim et al.   HEPATOLOGY